Unrecognized severe obstructive sleep apnea as a dominant risk factor for non-arteritic anterior ischemic optic neuropathy in an apparently healthy patient
Abstract
Introduction. Non-arteritic anterior ischemic optic neuropathy (NAION) is typically manifested by sudden, painless vision loss in one eye, often immediately upon waking up. The visual loss remains fairly stable over time but can be followed by similar manifestations in the fellow eye. One of the main causes for NAION is impaired hemodynamic regulation, followed by hypoperfusion of the optic nerve head. Recognized risk factors include arterial hypertension, hyperlipidemia, diabetes mellitus, smoking, etc. Case report. A 43-year-old man with a sudden painless right eye vision loss and typical symptoms and signs of NAION is presented. The ophthalmological examination, followed by fluorescein angiography and visual field testing, confirmed the diagnosis, while medical history had not revealed any of the standard risk factors. During hospitalization, the medical staff noted that the patient was snoring, waking up during the night while feeling short of breath, followed by excessive daytime sleepiness, which was later confirmed by family members as symptoms that had been present for several months. The patient was referred to a somnologist, who, after diagnostics, confirmed the presence of severe, untreated obstructive sleep apnea (OSA) and indicated treatment with a continuous positive air pressure (CPAP) device. The patient responded well to treatment, showing subjective and objective improvements in sleep quantity and quality. No progression of right eye NAION or vision impairments in the left eye has been noted after 6 months from diagnosis and CPAP introduction. Conclusion. OSA was probably the main underlying cause of NAION in this patient. We point out that OSA screening in high-risk patients can contribute to the early diagnosis and prevention of NAION.
References
Hattenhauer MG, Leavitt JA, Hodge DO, Grill R, Gray DT. In-cidence of nonarteritic anterior ischemic optic neuropathy. Am J Ophthamol 1997; 123(1): 103–7.
Salvetat ML, Pellegrini F, Spadea L, Salati C, Zeppieri M. Non-arteritic anterior ischemic optic neuropathy (NA-AION): a comprehensive overview. Vision (Basel) 2023; 7(4): 72.
Fraser JA, Rueløkke LL, Malmqvist L, Hamann S. Prevalence of optic disc drusen in young patients with nonarteritic anterior ischemic optic neuropathy: a 10-year retrospective study. J Neuroophthalmol 2021; 41(2): 200–5.
Distefano AG, Lam BL. Non-arteritic anterior ischemic optic neuropathy in pilots. Aerosp Med Hum Perform 2018; 89(11): 1005–7.
Totou S, Karmiris E, Kanakis M, Gartaganis P, Petrou P, Ka-logeropoulos C, et al. Impact of flight and equivalent short-term high-altitude exposure on ocular structures and function. Med Hypothesis Discov Innov Ophthalmol 2023; 12(3): 127–41.
American Academy of Sleep Medicine. International Classification of Sleep Disorders: Third edition. Text revision. Darien, IL: AASM; 2023.
Benjafield AV, Ayas NT, Eastwood PR, Heinzer R, Ip MSM, Morrell MJ, et al. Estimation of the global prevalence and bur-den of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med 2019; 7(8): 687–98.
Epstein LJ, Kristo D, Strollo PJ Jr, Friedman N, Malhotra A, Patil SP, et al. Clinical Guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. J Clin Sleep Med 2009; 5(3): 263–76.
American Academy of Sleep Medicine. The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications (Version 2.0). Darien, IL: AASM; 2012.
Kopitovic I, Trajanovic N, Prodic S, Drvenica MJ, Ilic M, Kuruc V, et al. The Serbian version of the Epworth sleepiness scale. Sleep Breath 2011; 15(4): 775–80.
Popević MB, Milovanović A, Nagorni-Obradović L, Nešić D, Mi-lovanović J, Milovanović AP. Screening commercial drivers for ob-structive sleep apnea: validation of STOP-Bang questionnaire. Int J Occup Med Environ Health 2017; 30(5): 751–61.
Bulloch G, Seth I, Zhu Z, Sukumar S, McNab A. Ocular manifes-tations of obstructive sleep apnea: a systematic review and meta-analysis. Graefes Arch Clin Exp Ophthalmol 2024; 262(1): 19–32.
Morsy NE, Amani BE, Magda AA, Nabil AJ, Pandi-Perumal SR, Bahammam AS, et al. Prevalence and Predictors of Ocular Complications in Obstructive Sleep Apnea Patients: A Cross-sectional Case-control Study. Open Respir Med J 2019; 13: 19–30.
Lei S, Micieli JA. Severe obstructive sleep apnea diagnosed af-ter non-arteritic anterior ischaemic optic neuropathy in a young man. BMJ Case Rep 2019; 12(11): e232512.
Sun MH, Lee CY, Liao YJ, Sun CC. Nonarteritic anterior is-chaemic optic neuropathy and its association with obstructive sleep apnoea: a health insurance database study. Acta Oph-thalmol 2019; 97(1): e64–70.
Li X, Zhang Y, Guo T, Liu K, Xu X, Fu Y, et al. Influence of obstructive sleep apnea syndrome on the contralateral optic nerve in patients with unilateral nonarteritic anterior ischemic optic neuropathy. J Clin Sleep Med 2023; 19(2): 347–53.
Gabbay J, Walter E, Kerman T, Amitai N, Gabay O, Hazan I, et al. Hypoperfusion states could increase the risk of non-arteritic anterior ischemic optic neuropathy. PLoS One 2024; 19(11): e0313098.
Chatziralli IP, Kazantzis D, Chatzirallis AP, Machairoudia G, Pa-pageorgiou EG, Theodossiadis GP, et al. Cardiometabolic factors and risk of non-arteritic anterior ischemic optic neuropathy: a systematic review and meta-analysis. Graefes Arch Clin Exp Ophthalmol 2022; 260(5): 1445–6.
Liu B, Yu Y, Liu W, Deng T, Xiang D. Risk factors for non-arteritic anterior ischemic optic neuropathy: a large scale me-ta-analysis. Front Med 2021; 8: 618353.
Petrović Pajić S, Marković I, Hawlina M. Leber hereditary optic neuropathy genotype, phenotype, and biochemical characteris-tics. Med Podml 2024; 75(2): 1–7.
Bucci FA Jr, Krohel GB. Optic nerve swelling secondary to the obstructive sleep apnea syndrome. Am J Ophthalmol 1988; 105(4): 428–30.
Hayreh SS, Zimmerman MB, Podhajsky P, Alward WL. Nonarte-ritic anterior ischemic optic neuropathy: Role of nocturnal ar-terial hypotension. Arch Ophthalmol 1997; 115(7): 942–5.
Landau K, Winterkorn JM, Mailloux LU, Vetter W, Napolitano B. 24-hour blood pressure monitoring in patients with anterior ischemic optic neuropathy. Arch Ophthalmol 1996; 114(5): 570–5.
Mojon DS, Mathis J, Zulauf M, Koerner F, Hess CW. Optic neu-ropathy associated with sleep apnea syndrome. Ophthalmolo-gy 1998; 105(5): 874–7.
Mojon DS, Hedges TR, Ehrenberg B, Karam EZ, Goldblum D, Abou-Chebl A, et al. Association Between Sleep Apnea Syn-drome and Nonarteritic Anterior Ischemic Optic Neuropathy. Arch Ophthalmol 2002; 120(5): 601–5.
Archer EL, Pepin S. Obstructive sleep apnea and nonarteritic anterior ischemic optic neuropathy: evidence for an associa-tion. J Clin Sleep Med 2013; 9(6): 613–8.
Stein JD, Kim DS, Mundy KM, Talwar N, Nan B, Chervin RD, et al. The association between glaucomatous and other causes of optic neuropathy and sleep apnea. Am J Ophthalmol 2011; 152(6): 989–99. e3.
Finkel KJ, Searleman AC, Tymkew H, Tanaka CY, Saager L, Saf-er-Zadeh E, et al. Prevalence of undiagnosed obstructive sleep apnea among adult surgical patients in an academic medical center. Sleep Med 2009; 10(7): 753–8.
Chang MY, Keltner JL. Risk Factors for Fellow Eye Involve-ment in Nonarteritic Anterior Ischemic Optic Neuropathy. J Neuroophthalmol 2019; 39(2): 147–52.
